Dymista nasal spray

Dymista is a nasal spray used for the treatment of allergic rhinitis, combining an antihistamine and a corticosteroid. Originally developed by AstraZeneca in the United States, it is now manufactured in multiple countries to meet global demand. AstraZeneca, headquartered in the United Kingdom, is the ultimate owner of the Dymista brand, ensuring its availability and distribution worldwide.